Article: CONCERTA(R) in the Classroom: New Data on Attention in Children With ADHD.

LAS VEGAS, Nov. 4 /PRNewswire/ -- New findings presented today show that CONCERTAA' (OROSA' methylphenidate HCl Extended-Release Tablets CII) is the only stimulant medication with data that demonstrate a significant treatment effect on attention at one hour and through 12.5 hours in children with Attention Deficit Hyperactivity Disorder (ADHD). ADHD is a common and treatable medical condition characterized by inattention, hyperactivity and impulsivity(1) that is estimated to affect about 5 million children(2) in the United States.

 
  (Logo: http://www.newscom.com/cgi-bin/prnh/20091104/CG04247LOGO-a) 
  (Logo: ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!